Moderna (MRNA) PT Raised to $68 at Roth Capital
Tweet
Share
E-mailGet Alerts MRNA Hot Sheet
Price: $145.13 +8.86%
Rating Summary:
6 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Rating Summary:
6 Buy, 21 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 8 | Down: 5 | New: 26
Join SI Premium – FREE
Roth Capital analyst Yasmeen Rahimi raised the price target on Moderna (NASDAQ: MRNA) to $68.00 (from $41.00) while maintaining a Buy rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Moderna (MRNA) PT Raised to $77 at JPMorgan
- Moderna (MRNA) call put ratio 1 calls to 2.1 puts amid wide price movement
- Guggenheim Reiterates Buy Rating on Merck (MRK)
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
Roth CapitalSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
